Welcome to our dedicated page for Butterfly Network news (Ticker: BFLY), a resource for investors and traders seeking the latest updates and insights on Butterfly Network stock.
Butterfly Network Inc (NYSE: BFLY) pioneers accessible medical imaging solutions through its revolutionary Ultrasound-on-Chip™ technology. This dedicated news hub provides investors and healthcare professionals with essential updates on product innovations, financial developments, and strategic initiatives driving the future of point-of-care diagnostics.
Discover official press releases covering earnings announcements, regulatory milestones, and partnerships advancing AI-powered ultrasound technology. Our curated collection ensures timely access to verified information about BFLY's handheld imaging systems, educational programs, and market expansion efforts.
Key updates include product launch details, clinical validation studies, and executive leadership changes. Bookmark this page to monitor how Butterfly Network's cloud-connected devices and ScanLab™ training tools continue transforming medical imaging accessibility worldwide.
Butterfly Network (NYSE: BFLY) reported Q3 2025 results with $21.5M revenue (5% YoY) and reaffirmed full-year revenue guidance of $91M–$95M. The company reduced quarterly cash burn to a record low of $3.9M and held $144.2M cash at quarter-end. GAAP gross margin swung to a (17.5%) loss due to a $17.4M inventory write-down while adjusted gross margin rose to 63.9%. Net loss widened to $34.0M and adjusted EBITDA loss improved slightly to $8.1M. Operational milestones included ISO 27001, a JAMA clinical validation, FDA-submitted gestational-age AI, third-party app launch in Butterfly Garden, and P5.1 chip completion.
Butterfly Network (NYSE: BFLY) said its CEO and interim CFO will participate at the UBS Global Healthcare Conference in Palm Beach, FL on Tuesday, November 11, 2025 at 5:00 pm ET.
Joseph DeVivo, President, CEO & Chairman and Megan Carlson, SVP & Interim CFO will take part in a fireside chat and host one-on-one investor meetings. A live webcast will be available in the Events & Presentations section of the Butterfly investor website and will be available for replay after the event. One-on-one meetings are scheduled through UBS representatives.
Butterfly Network (NYSE:BFLY) announced it achieved multiple information-security accreditations on October 27, 2025, reinforcing its global data-protection posture.
The company obtained ISO 27001, SOC-2 Type 2, C5 Germany, and the NHS DSPT certifications, and was assessed by third-party auditor A-LIGN. Management said these certifications support enterprise-grade, secure medical imaging for hospitals and health systems across the US, UK, EU, and international markets.
The release also reiterates prior milestones: a 2024 GovRAMP Snapshot (first in medical imaging) and ongoing pursuits of full GovRAMP authorization, TX-RAMP, FedRAMP, and HITRUST CSF r2.
Butterfly Network (NYSE: BFLY) will report third quarter 2025 financial results on October 31, 2025 before market open.
Joseph DeVivo, President and CEO, and Megan Carlson, Interim CFO, will host a conference call and webcast at 8:00 AM ET on October 31 to discuss financial and operational results. The live webcast will be available on Butterfly's Investor Relations Events & Presentations page and will be archived after the call.
Telephone participants may dial in ~10 minutes early: US Toll-Free +1 833-470-1428 or US Local +1 646-844-6383 using Access Code 849303. A telephone replay is available until November 7, 2025 at US Local +1 929-458-6194 or US Toll-Free +1 866-813-9403 with Access Code 583803.
Butterfly Network (NYSE: BFLY) appointed John Doherty as Executive VP and Chief Financial Officer, effective December 8, 2025. Doherty brings over 25 years of global financial leadership including roles as CFO at Kaltura, CFO/COO at Magic Leap (secured >$1B financing and led a recapitalization), and CFO at InterXion (drove >60% revenue and EBITDA growth, led a $320M equity offering, and helped enable an $8B combination). At Verizon he participated in >$100B of strategic transactions. Management says Doherty joins as Butterfly has a successful product launch, a strengthened balance sheet, and a defined path toward breakeven. Interim CFO Megan Carlson will return to her role as Chief Accounting Officer and SVP Finance & Accounting.
Butterfly Network (NYSE:BFLY) launched an AI-powered blind-sweep Gestational Age tool in Malawi and Uganda on October 6, 2025, designed to let lower-skilled staff estimate gestational age without image interpretation or training.
The model was developed with the Gates Foundation and University of North Carolina and trained on African population data. The tool is pending US FDA review. Butterfly also reported its Gates-funded 1,000 Probe Partnership (Sep 2022–Dec 2024): 1,000 iQ+ probes deployed, 1,050+ providers trained, 697+ facilities served and 1.8M scans recorded as of July 2025.
Butterfly Network (NYSE:BFLY), a digital health company specializing in handheld ultrasound technology, has been recognized in TIME's inaugural World's Top HealthTech Companies 2025 list. The company was selected among 400 leading innovators from thousands of candidates, based on financial performance, reputation, and online engagement metrics.
Butterfly's innovative Ultrasound-on-Chip™ technology has transformed traditional ultrasound systems into a single, whole-body handheld probe. Their latest iQ3 device features AI-powered capabilities and enhanced image capture, making diagnostic imaging more accessible at the point of care. The company's technology aims to democratize ultrasound access across various healthcare settings, from resource-limited environments to advanced hospital systems.
Butterfly Network (NYSE:BFLY), a digital health company specializing in portable ultrasound technology, has appointed Victor Ku as Senior Vice President and Chief Technology Officer. Ku will join in late September 2025 to lead the company's global technology strategy, product development, and innovation roadmap.
Ku brings over 20 years of leadership experience in regulated and high-tech environments, with expertise in semiconductor-based imaging. He previously served as VP of R&D at Headwall Photonics and held senior positions at Teledyne FLIR and EFI. He holds a PhD from Oxford University and an Executive Certificate from MIT.
Butterfly Network (NYSE:BFLY) announced the publication of significant clinical trial results in JAMA demonstrating the effectiveness of their POCUS (Point-of-Care Ultrasound) program. The POCUS-CARE trial, conducted at Rutgers Robert Wood Johnson Medical School, showed that implementing Butterfly's ultrasound technology with AI assistance led to substantial improvements in hospital efficiency.
The study of 208 patients revealed that the POCUS program resulted in 246 hospital bed-days saved and $751,537 in direct cost savings. The POCUS group demonstrated a 30% reduction in expected hospital length of stay (8.3 vs. 11.9 days), with the technology changing clinical management in 35% of cases. The program focused particularly on lung ultrasound for pulmonary congestion assessment, supported by Butterfly's FDA-cleared Auto B-line Counter.
Butterfly Network (NYSE:BFLY) has announced a strategic distribution agreement with Clipper Distributing to commercialize its point-of-care ultrasound devices in the veterinary market. The partnership will focus on distributing the Butterfly iQ+ Vet, the world's only handheld, single-probe, whole-body, multi-species imaging system.
The collaboration leverages Butterfly's proprietary Ultrasound-on-Chip™ technology and Butterfly Cloud workflow management software, combined with Clipper's extensive distribution network in the veterinary health market. The second and third generation probes feature enhanced imaging capabilities, procedural guidance tools, and improved usability features designed specifically for veterinary applications.
FAQ
What is the current stock price of Butterfly Network (BFLY)?
What is the market cap of Butterfly Network (BFLY)?
